Oliver Kooistra, PhD medac GmbH

Oliver Kooistra has been with medac for ten years, initially as project manager drug regulatory affairs and pharmaceutical development, since reorganization in 2009 in pharmaceutical development. For the last six years he has been involved in the development of a methotrexate auto injector for rheumatoid arthritis indications that has meanwhile been authorized for marketing in the US, EU and many other countries. Before joining medac, Oliver Kooistra worked for four years in analytical development at Eli Lilly & Co, Hamburg, Germany. Oliver Kooistra is a biologist and received his PhD in analytical chemistry from University of Lübeck.